Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/25/2026 | Q4 | $379.5M | -- | -- | -$0.73 | -- |
| 11/03/2025 | Q3 | $337M | $399.4M | -$1.80 | -$0.37 | -$1.42 |
| 08/06/2025 | Q2 | $531M | $611.1M | $1.89 | $1.16 | $0.73 |
| 05/06/2025 | Q1 | $684.1M | $744.9M | -$4.60 | -$0.65 | -$3.95 |
| 02/26/2025 | Q4 | $631M | $658.4M | $1.61 | $2.06 | -$0.45 |
| 11/06/2024 | Q3 | $405.1M | $467.2M | $0.34 | $0.37 | -$0.03 |
| 08/07/2024 | Q2 | $387.3M | $362.9M | $0.07 | $0.47 | -$0.40 |
| 05/01/2024 | Q1 | $375.4M | $413.5M | $0.36 | $0.41 | -$0.05 |
| 02/28/2024 | Q4 | $386.2M | $396.8M | $0.43 | $0.37 | $0.06 |
| 11/01/2023 | Q3 | -- | $331.8M | -$0.46 | -- | -- |
| 08/02/2023 | Q2 | -- | $261.2M | -$0.27 | -- | -- |
| 05/02/2023 | Q1 | -- | $253.5M | -$5.86 | -- | -- |
| 02/28/2023 | Q4 | -- | $258.4M | -$1.24 | -- | -- |
| 11/02/2022 | Q3 | -- | $230.3M | -$2.94 | -- | -- |
| 08/02/2022 | Q2 | -- | $233.5M | -$2.65 | -- | -- |
| 05/04/2022 | Q1 | -- | $210.8M | -$1.20 | -- | -- |
| 03/01/2022 | Q4 | -- | $201.5M | -$1.42 | -- | -- |
| 11/03/2021 | Q3 | -- | $189.4M | -$0.60 | -- | -- |
| 08/04/2021 | Q2 | -- | $164.1M | -$1.02 | -- | -- |
| 05/05/2021 | Q1 | -- | $146.9M | -$2.11 | -- | -- |
| 03/01/2021 | Q4 | -- | $145.1M | -$2.40 | -- | -- |
| 11/05/2020 | Q3 | -- | $143.9M | -$2.50 | -- | -- |
| 08/05/2020 | Q2 | -- | $137.4M | -$1.93 | -- | -- |
| 05/06/2020 | Q1 | -- | $113.7M | -$0.23 | -- | -- |
| 02/26/2020 | Q4 | -- | $100.1M | -$3.16 | -- | -- |
| 11/07/2019 | Q3 | -- | $99M | -$1.70 | -- | -- |
| 08/07/2019 | Q2 | -- | $94.7M | -$3.74 | -- | -- |
| 05/08/2019 | Q1 | -- | $87M | -$1.07 | -- | -- |
| 02/27/2019 | Q4 | -- | $84.4M | -$2.05 | -- | -- |
| 10/24/2018 | Q3 | -- | $78.5M | -$1.15 | -- | -- |
| 08/08/2018 | Q2 | -- | $73.5M | -$1.67 | -- | -- |
| 05/03/2018 | Q1 | -- | $64.6M | -$0.55 | -- | -- |
| 03/01/2018 | Q4 | -- | $57.3M | -$0.37 | -- | -- |
| 10/25/2017 | Q3 | -- | $46M | -$0.78 | -- | -- |
| 07/19/2017 | Q2 | -- | $35M | -$1.15 | -- | -- |
| 04/27/2017 | Q1 | -- | $16.3M | $1.50 | -- | -- |
| 02/28/2017 | Q4 | -- | $5.4M | -$1.62 | -- | -- |
| 10/27/2016 | Q3 | -- | -- | -$1.18 | -- | -- |
| 07/19/2016 | Q2 | -- | -- | -$1.35 | -- | -- |
| 05/05/2016 | Q1 | -- | -- | -$1.31 | -- | -- |
| 02/25/2016 | Q4 | -- | $1.3M | -$1.44 | -- | -- |
Sarepta Therapeutics, Inc. reported $399.4M worth of top line sales in its most recent quarter.
Sarepta Therapeutics, Inc. announced earnings per share of -$1.80 which represents a miss of analyst forecast a -$0.37 per share.
Sarepta Therapeutics, Inc. reported $230.1M that represents $2.30 per share over the last quarter.
Sarepta Therapeutics, Inc.'s earnings are forecast to decrease from $2.34 per share to $4.02 per share next year representing a decrease of -95.56%.
Sarepta Therapeutics, Inc.'s next earnings date is February 25, 2026.
Signup to receive the latest stock alerts
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Market Cap: $4.5T
P/E Ratio: 63x
Market Cap: $4T
P/E Ratio: 36x
Market Cap: $3.8T
P/E Ratio: 39x
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
UniFirst Corp. [UNF] is up 0.77% over the past day.